Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

OpenNIH

Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)

Oct 19, 2026
Closes
View opportunity →
OpenNIH

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

$1,800,000
Total funding
Oct 19, 2026
Closes
View opportunity →
OpenNIH

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

$2,600,000
Total funding
Oct 19, 2026
Closes
View opportunity →
OpenNIH

Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)

$1,000,000
Total funding
Oct 19, 2026
Closes
View opportunity →
OpenNIH

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

$50,000
Award ceiling
Oct 19, 2026
Closes
View opportunity →
OpenNIH

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)

$3,600,000
Total funding
Oct 20, 2026
Closes
View opportunity →
OpenNIH

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)

$1,500,000
Total funding
Oct 22, 2026
Closes
View opportunity →
OpenNIH

GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)

$2,000,000
Total funding
Oct 30, 2026
Closes
View opportunity →
OpenNIH

GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

$3,000,000
Total funding
Oct 30, 2026
Closes
View opportunity →
OpenNIH

GREGoRi Innovation Projects (U01 Clinical Trial Optional)

$7,500,000
Total funding
Oct 30, 2026
Closes
View opportunity →
OpenNIH

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

Oct 30, 2026
Closes
View opportunity →
OpenNIH

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

Nov 2, 2026
Closes
View opportunity →